You can buy or sell THTX and other stocks, options, and ETFs commission-free!
Theratechnologies Inc. Common Shares, also called Theratechnologies, is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada. The listed name for THTX is Theratechnologies Inc. Common Shares.
52 Week High
52 Week Low
— per share
-$0.07 per share